BIO GREEN MED SOLUTION INC (BGMS) Stock Price, Forecast & Analysis
NASDAQ:BGMS • US23254L8761
BGMS Key Statistics, Chart & Performance
The current stock price of BGMS is 1.07 USD. In the past month the price decreased by -26.86%.
BGMS Technical Analysis
BGMS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BGMS. BGMS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BGMS Financial Highlights
Over the last trailing twelve months BGMS reported a non-GAAP Earnings per Share(EPS) of -80.13. The EPS increased by 96.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.49% | ||
| ROE | -98.28% | ||
| Debt/Equity | 0 |
BGMS Forecast & Estimates
For the next year, analysts expect an EPS growth of 39.49% and a revenue growth 88.68% for BGMS
BGMS Ownership
BGMS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.75 | 411.552B | ||
| AMGN | AMGEN INC | 16.85 | 201.047B | ||
| GILD | GILEAD SCIENCES INC | 17.12 | 192.64B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.07 | 121.106B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.05 | 83.892B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 49.66 | 43.941B | ||
| INSM | INSMED INC | N/A | 32.101B | ||
| NTRA | NATERA INC | N/A | 29.393B | ||
| BIIB | BIOGEN INC | 12.76 | 28.709B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.15 | 20.773B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BGMS
Company Profile
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. The company provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
Company Info
BIO GREEN MED SOLUTION INC
Level 10, Tower 11, Avenue 5, No. 8, Jalan Kerinchi
KUALA LUMPUR NEW JERSEY MY
Employees: 0
Phone: 609085177330
BIO GREEN MED SOLUTION INC / BGMS FAQ
What does BIO GREEN MED SOLUTION INC do?
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. The company provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
Can you provide the latest stock price for BIO GREEN MED SOLUTION INC?
The current stock price of BGMS is 1.07 USD. The price increased by 3.88% in the last trading session.
Does BIO GREEN MED SOLUTION INC pay dividends?
BGMS does not pay a dividend.
What is the ChartMill rating of BIO GREEN MED SOLUTION INC stock?
BGMS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the employee count for BGMS stock?
BIO GREEN MED SOLUTION INC (BGMS) currently has 0 employees.
Can you provide the market cap for BIO GREEN MED SOLUTION INC?
BIO GREEN MED SOLUTION INC (BGMS) has a market capitalization of 5.24M USD. This makes BGMS a Nano Cap stock.